C16H14F3N3O2S
| 中文名称: | 兰索拉唑 |
| 中文同义词: | 2-[[[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰]-1H-苯并咪唑;郎索那唑;2-[3-甲基-4-(2,2,2-村氟乙氧基)-2-吡啶基]亚磺酰]-1H-苯并咪唑;达克普隆;兰索拉唑;2-[[[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑;2-(((3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基)亚磺酰基)-1H-苯并咪唑;兰索拉唑及中间体 |
| 英文名称: | Lansoprazole |
| 英文同义词: | LANSOPRAZOLE, RELATED COMPOUND A2-[[[3-METHYL-4-(2,2,2-TRIFLOUROETHOXY)-2-PYRIDYL]METHYL]SULFONYL]BENZIMIDAZOLE USP STANDARD;LANSOPRAZOLE, MM(CRM STANDARD);LANSOPRAZOLE USP(CRM STANDARD);2-[3-METHYL-4-(2,2,2-TRIFLUORO-ETHOXY)-PYRIDIN-2-YLMETHANESULFINYL]-1H-BENZOIMIDAZOLE;Lansoprazole99.5%;A-65006, AG-1749, Agopton, Lansox, Lanzor, Limpidex, Ogast, Prevacid,;1H-Benzimidazole, 2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-;LANSORAZOLE |
| CAS号: | 103577-45-3 |
| 分子式: | C16H14F3N3O2S |
| 分子量: | 369.36 |
| EINECS号: | 2017-001-1 |
| 相关类别: | Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Ion Pump Inhibitors;Monovalent Ion Channels;Voltage-gated Ion Channels;物;ATPase;Pharmaceutical Intermediates;API Reference StandardFree Base API;Other APIs;医药中间体;医药原料;医药研发及中间体;有机原料; |
| Mol文件: | 103577-45-3.mol |
